Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study.

Chad Tang,Jeremiah Sanders,Howard Thames,David M Swanson,Juanita M Crook,Teresa Bruno,Pierre Blanchard,Jay Ciezki,Mira Keyes,Daniel Song,Tanmay Singh,Gregory Merrick,Richard Stock,Francis J Sullivan,Henry Mok,Jeremy Millar,Steven J Frank

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology（2023）

引用 0|浏览47

暂无评分

摘要

Pd-103 monotherapy was associated with higher FFBF, FFCF, and biochemical cure rates, and suggests that Pd-103 LDR may lead to improved oncologic outcomes compared with I-125.

查看译文

关键词

Brachytherapy,I-125,Low dose rate,Pd-103,Prostate Cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要